Nebraska Center for Integrated Biomolecular Communication (CIBC)
内布拉斯加州综合生物分子通讯中心 (CIBC)
基本信息
- 批准号:10271829
- 负责人:
- 金额:$ 145.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-15 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAreaAwardBioinformaticsBiologicalBiological SciencesBiomedical ResearchBiosensing TechniquesCARTPT geneCellsChemicalsChromatinCollaborationsCommunicationCommunitiesComplexComputer ModelsCore FacilityCryoelectron MicroscopyDataData AnalysesData ScienceDetectionDevelopmentDiagnosisDisciplineDiseaseDisease PathwayE-learningEducational workshopEngineeringEquipmentEvaluationFacultyFosteringFourier transform ion cyclotron resonanceFundingGenetic TranscriptionGoalsGrantInterdisciplinary CommunicationInterdisciplinary StudyInternationalKnowledgeMass Spectrum AnalysisMedical centerMetabolic PathwayMethodologyMethodsMolecularMolecular ProbesMutationNatureNebraskaOutcomeOutcomes ResearchPathway interactionsPeer ReviewPeptide ReceptorPeptidesPhasePhysiologicalPilot ProjectsPositioning AttributeProblem SolvingPublicationsRegulationRegulatory PathwayResearchResearch ActivityResearch InfrastructureResearch PersonnelResearch SupportS PhaseSecureSeedsSeriesServicesStatistical Data InterpretationSystemSystems BiologyTechniquesTechnologyTimeTrainingUniversitiesWaterbasecareer developmentcohortcollegecomputational platformdata managementdata miningdata portaldata sharingdesignhuman diseaseimaging capabilitiesimprovedinnovationmembermethicillin resistant Staphylococcus aureusmultidisciplinarynew technologynovelnovel therapeutic interventionpathogenrecruitstructural biologysuccesstraining opportunitytreatment strategyunnatural amino acids
项目摘要
PROJECT SUMMARY/ABSTRACT
Regulation of biomolecular communication pathways is critical to maintaining physiological function. Unraveling
these pathways and filling in critical knowledge gaps will provide novel opportunities to understand, diagnose,
and treat human diseases. During Phase 1, the Nebraska Center for Integrated Biomolecular Communication
(CIBC) supported 15 early stage investigators (ESIs), helped recruit four new faculty members to the University
of Nebraska-Lincoln (UNL), and established two research cores. CIBC’s ESIs secured $16.7 million in external
research funds and authored 82 peer-reviewed publications. Building on Phase 1, the goal of the CIBC in Phase
2 is to continue building a critical mass of biomedical investigators and supporting research infrastructure in the
area of biomolecular communication pathways at UNL that will position CIBC for a successful transition to long-
term sustainability in Phase 3. CIBC will continue to develop multidisciplinary teams to interrogate complex
disease pathways, especially by connecting researchers developing new molecular probes and analytical
techniques with those unravelling molecular mechanisms of human diseases. CIBC’s Phase 2 specific aims
are to: 1) strengthen UNL’s biomedical research infrastructure by supporting the research efforts and career
development of biomedical investigators whose research is broadly focused on understanding the regulation of
biomedically relevant communication pathways; 2) enhance research capabilities by maintaining and expanding
the Systems Biology Core (SBC) to facilitate acquisition of essential bioanalytical data and the Data and Life
Sciences Core (DLSC) to provide critical bioinformatics support and data management, storage, and sharing to
Center members; and 3) advance interdisciplinary research collaborations with broad disciplinary representation
to pursue high-impact research into complex disease from diverse perspectives. The initial Phase 2 Project
Leaders will pursue projects interrelated by their fundamental focus on different aspects of the biomolecular
basis of disease-associated communication pathways. These projects, which signify CIBC’s interdisciplinary
nature, are directed toward: 1) developing novel chemical probes and targeted mass spectrometry approaches
to study the cocaine and amphetamine-regulated transcript peptide and receptor(s), 2) understanding how the
7SK RNP regulates transcription and its implications in human diseases, 3) conducting near real-time detection
of methicillin-resistant S. aureus by developing a generalizable electrochemical peptide-based biosensing
platform, and 4) developing a novel Unnatural Amino Acid-based Chromatin Isolation Method (UChIMe) with
improved accuracy and sensitivity. CIBC will further expand SBC and DLSC to enable Nebraska’s biomedical
researchers to pursue high-impact biomedical research. CIBC’s innovation is in integrating the research activities
of chemists, biochemists, engineers, and bioinformaticians to understand how cells communicate and integrate
metabolic and regulatory pathways relevant to disease development and progression.
项目摘要/摘要
生物分子通信途径的调节对于维持生理功能至关重要。解开
这些途径和填补关键知识差距将为理解,诊断,
并治疗人类疾病。在第1阶段,内布拉斯加州综合生物分子通信中心
(CIBC)支持15名早期调查员(ESI),帮助招募了四名新教师到该大学
内布拉斯加州 - 林肯(UNL),并建立了两个研究核心。 CIBC的ESI为外部获得了1670万美元
研究资金并撰写了82个同行评审的出版物。在第1阶段建立CIBC的目标
2是继续建立大量的生物医学研究人员,并支持研究基础设施
UNL处的生物分子通信途径的区域将使CIBC成功过渡到长期
第3阶段的可持续性。CIBC将继续发展多学科团队以询问复杂
疾病途径,尤其是通过连接研究新分子问题和分析的研究人员
具有人类疾病的分子机制的技术。 CIBC的第二阶段特定目标
是:1)Strong Unl的生物医学研究基础设施通过支持研究工作和职业
生物医学研究人员的开发,其研究主要集中于了解调节
与生物医学相关的交流途径; 2)通过维护和扩展来增强研究能力
系统生物学核心(SBC)促进基本生物分析数据和数据和生活
科学核心(DLSC)提供关键的生物信息学支持和数据管理,存储和共享
中心成员; 3)提前学科的跨学科研究合作,具有广泛的纪律代表
从潜水员的角度来追求对复杂疾病的高影响研究。初始第2阶段项目
领导者将购买与生物分子不同方面的基本关注相关的项目
与疾病相关的沟通途径的基础。这些项目,表示CIBC的跨学科
大自然,针对以下方面:1)发展新的化学问题和靶向质谱法
研究可卡因和苯丙胺调节的转录本肽和接收器(S),2)
7SK RNP调节转录及其对人类疾病的影响,3)进行接近实时检测
通过开发可推广的基于电化学肽的生物传感的耐甲氧西林金黄色葡萄球菌的
平台和4)开发一种新型的非天然氨基酸染色质分离方法(UCHIME)
提高了准确性和灵敏度。 CIBC将进一步扩展SBC和DLSC以启用内布拉斯加州的生物医学
研究人员纯化高影响力生物医学研究。 CIBC的创新在于整合研究活动
化学家,生物化学家,工程师和生物信息学家,以了解细胞如何进行通信和整合
与疾病发展和进展有关的代谢和调节途径。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jiantao Guo其他文献
Jiantao Guo的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jiantao Guo', 18)}}的其他基金
Developing synthetic chemical biology strategies for biochemical investigations and biomedical applications
开发用于生化研究和生物医学应用的合成化学生物学策略
- 批准号:
10623497 - 财政年份:2023
- 资助金额:
$ 145.26万 - 项目类别:
Defining, studying, and targeting sulfated tyrosine residues of cell surface receptors for disease treatment
定义、研究和靶向细胞表面受体的硫酸化酪氨酸残基用于疾病治疗
- 批准号:
10504069 - 财政年份:2022
- 资助金额:
$ 145.26万 - 项目类别:
Development of proximity-induced fluorogenic reactions for imaging biomolecular interaction through noncanonical amino acid mutagenesis in response to quadruplet codon and recoding signal
开发邻近诱导的荧光反应,通过响应四联体密码子和重新编码信号的非规范氨基酸诱变来成像生物分子相互作用
- 批准号:
10033286 - 财政年份:2020
- 资助金额:
$ 145.26万 - 项目类别:
Development of proximity-induced fluorogenic reactions for imaging biomolecular interaction through noncanonical amino acid mutagenesis in response to quadruplet codon and recoding signal
开发邻近诱导的荧光反应,通过响应四联体密码子和重新编码信号的非规范氨基酸诱变来成像生物分子相互作用
- 批准号:
10259702 - 财政年份:2020
- 资助金额:
$ 145.26万 - 项目类别:
Nebraska Center for Integrated Biomolecular Communication (CIBC)
内布拉斯加州综合生物分子通讯中心 (CIBC)
- 批准号:
10488641 - 财政年份:2016
- 资助金额:
$ 145.26万 - 项目类别:
Nebraska Center for Integrated Biomolecular Communication (CIBC)
内布拉斯加州综合生物分子通讯中心 (CIBC)
- 批准号:
10704185 - 财政年份:2016
- 资助金额:
$ 145.26万 - 项目类别:
Improve the safety of an efficacious live-attenuated HIV-1 vaccine through unnatu
通过 unnatu 提高有效的 HIV-1 减毒活疫苗的安全性
- 批准号:
8706615 - 财政年份:2014
- 资助金额:
$ 145.26万 - 项目类别:
Improve the safety of an efficacious live-attenuated HIV-1 vaccine through unnatu
通过 unnatu 提高有效的 HIV-1 减毒活疫苗的安全性
- 批准号:
8837571 - 财政年份:2014
- 资助金额:
$ 145.26万 - 项目类别:
相似国自然基金
跨区域调水工程与区域经济增长:效应测度、机制探究与政策建议
- 批准号:72373114
- 批准年份:2023
- 资助金额:40 万元
- 项目类别:面上项目
农产品区域公用品牌地方政府干预机制与政策优化研究
- 批准号:72373068
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
新型城镇化与区域协调发展的机制与治理体系研究
- 批准号:72334006
- 批准年份:2023
- 资助金额:167 万元
- 项目类别:重点项目
我国西南地区节点城市在次区域跨国城市网络中的地位、功能和能级提升研究
- 批准号:72364037
- 批准年份:2023
- 资助金额:28 万元
- 项目类别:地区科学基金项目
多时序CT联合多区域数字病理早期预测胃癌新辅助化疗抵抗的研究
- 批准号:82360345
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
The Role of Glycosyl Ceramides in Heart Failure and Recovery
糖基神经酰胺在心力衰竭和恢复中的作用
- 批准号:
10644874 - 财政年份:2023
- 资助金额:
$ 145.26万 - 项目类别:
Assessing Native Hawaiian and Pacific Islander Maternal Outcomes and Health Care Experiences
评估夏威夷原住民和太平洋岛民的产妇结局和医疗保健体验
- 批准号:
10644888 - 财政年份:2023
- 资助金额:
$ 145.26万 - 项目类别:
HEAR-HEARTFELT (Identifying the risk of Hospitalizations or Emergency depARtment visits for patients with HEART Failure in managed long-term care through vErbaL communicaTion)
倾听心声(通过口头交流确定长期管理护理中的心力衰竭患者住院或急诊就诊的风险)
- 批准号:
10723292 - 财政年份:2023
- 资助金额:
$ 145.26万 - 项目类别:
Development and implementation of a digital sleep intervention for preschoolers in foster care
为寄养中的学龄前儿童开发和实施数字睡眠干预
- 批准号:
10724304 - 财政年份:2023
- 资助金额:
$ 145.26万 - 项目类别:
Implementing Evidence-Based Treatment for Common Mental Disorders in HIV Clinics in Ukraine
在乌克兰艾滋病毒诊所对常见精神疾病实施循证治疗
- 批准号:
10762576 - 财政年份:2023
- 资助金额:
$ 145.26万 - 项目类别: